Bayer Aktiengesellschaft (ETR:BAYN) Shares Up 0.4% – Still a Buy?

Bayer Aktiengesellschaft (ETR:BAYN) shot up 0.4% on Wednesday . The stock traded as high as €19.99 ($20.61) and last traded at €19.79 ($20.40). 3,072,022 shares changed hands during trading, The stock had previously closed at €19.72 ($20.33).

Bayer Aktiengesellschaft Trading Down 0.6 %

The company has a 50 day moving average of €20.46 and a 200 day moving average of €24.88. The firm has a market cap of $19.32 billion, a price-to-earnings ratio of -15.25, a price-to-earnings-growth ratio of 36.39 and a beta of 0.97. The company has a current ratio of 1.27, a quick ratio of 0.72 and a debt-to-equity ratio of 129.94.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.